Skip to main content
. Author manuscript; available in PMC: 2020 Jul 15.
Published in final edited form as: Clin Cancer Res. 2019 Apr 11;25(14):4375–4387. doi: 10.1158/1078-0432.CCR-18-4144

Table 1.

Characteristics of oligodendroglial tumors used in xenograft assays

Cell line Histology Xenograft-induced
lethality
Mutation in PI3K/Akt/mTOR pathway
YMG5 AOD Yes PIK3R1 I571NfsTer31
YMG6R3T AOD Yes PIK3CA E542K
YMG6R4T AOD Yes PIK3CA E542K
YMG23 AOD Yes PIK3CA H1047R
MGG60 AOD Yes PIK3CA H1047L
MGG137 AOD Yes mTOR S2215F
YMG6R3F AOD No None
YMG28 AOD No None
YMG46 OD No PIK3CA E469G
YMG53 AOD No None
MGG78 OD No None
MGG82 AOD No None
MGG109 AOD No None
MGG126 AOD No None
MGG130 AOD No None